Who We Are
The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research.
- Funded +2,000 research programs
- Raised $745+ million
- Founded in 1993
Donate to Speed Research and Help Cure Prostate Cancer
Help us speed up scientific breakthroughs and deliver new treatments to prostate cancer patients.
Donate to research
People recently donated to
Choose a project to support it directly
How It Works
-
Tell us about you
Answer a few questions that will help us find research projects for your interests
-
We match you with research projects
Based on your answers we'll suggest relevant research projects for you to back
-
Back a project and stay updated
Take action and donate to 1 or more of the suggested projects
Stevie Dupin with his family
Stand-up comic, TV producer, book author, husband and father. Diagnosed with prostate cancer at 42.
We Give People Hope
The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research.
81%
81 cents of every dollar donated goes to our prostate cancer research mission.
Some of our partners:
PCF Prostate Cancer Patient Guide
The Prostate Cancer Patient Guide, compiled with the contributions of top-tier doctors and researchers in prostate cancer, is a must-have resource for prostate cancer patients. It focuses all of the information available about contemporary prostate cancer research, treatment, and lifestyle factors into one consolidated document.
- Newly diagnosed men
- Men in treatment
- Men concerned about a rising PSA
- Caregivers who want to get the need-to-know information
Patient Stories
Jeff’s ability to focus on the good things, and his positive outlook, are essential, says Lee, who points out that there is more reason to be positive about metastatic prostate cancer than ever before.
Jeff Finerman
Jeff Finerman and his wife, Karen.
Mark’s cancer stems from the BRCA2 mutation, so when his oncologist (PCF funded researcher Heather Cheng) was planning a form of attack she thought outside of the box: treat the genetic mutation, not the prostate.
Mark Meerschaert
Mathematics professor and researcher
“I had an expected expiration date. Now, with participating in this study, that’s taken away. I don’t see an expiration date any more – or if there is one, it’s years out, as opposed to months out.”
Chris Seelye
U.S. Navy Veteran, professional photographer
Ready to donate to prostate cancer research?
- Help promising research ideas happen
- Receive updates about research relevant to you
- Fund brilliant individuals and teams of scientists
- Cut through red tape, speed scientific breakthroughs